GMED - Company ID 0001237831
The table below shows GLOBUS MEDICAL INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $2.94B | $2.52B | $1.57B | $1.02B | $958.10M | $789.04M |
| Cost of revenue | $957.80M | $1.04B | $548.17M | $263.73M | $239.22M | $217.46M |
| Gross profit | - | - | $1.02B | $759.12M | $718.88M | $571.58M |
| R&D | $147.25M | $163.75M | $124.01M | $73.02M | $97.35M | $84.52M |
GLOBUS MEDICAL INC reported annual revenue of $2.94B for fiscal year 2025. That is up 16.7% from $2.52B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $563.99M (FY 2016) to $2.94B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $1.18B |
| $981.36M |
| $643.84M |
| $432.12M |
| $408.15M |
| $354.76M |
| Operating income | $479.82M | $165.99M | $133.14M | $227.95M | $171.95M | $111.43M |
| Income tax | $67.20M | $17.74M | $42.52M | $52.85M | $31.22M | $23.61M |
| Net income | $537.87M | $102.98M | $122.87M | $190.17M | $149.19M | $102.28M |
| EPS (diluted) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 |